Cleared Traditional

K132667 - SYNERGY ODM

K132667 is the FDA 510(k) clearance for SYNERGY ODM by Topcon Medical Systems, Inc.. It is a Class 2 Ophthalmic device (product code NFJ) cleared through the Traditional 510(k) pathway after a 43-day FDA review.

K132667 · Topcon Medical Systems, Inc. · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2013
Decision
43d
Days
Class 2
Risk

K132667 is an FDA 510(k) clearance for the SYNERGY ODM. Classified as System, Image Management, Ophthalmic (product code NFJ), Class II - Special Controls.

Submitted by Topcon Medical Systems, Inc. (North Reading, US). The FDA issued a Cleared decision on October 9, 2013 after a review of 43 days - a notably fast clearance cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 892.2050 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Topcon Medical Systems, Inc. devices

Submission Details

510(k) Number K132667 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 27, 2013
Decision Date October 09, 2013
Days to Decision 43 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
67d faster than avg
Panel avg: 110d · This submission: 43d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code NFJ System, Image Management, Ophthalmic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - NFJ System, Image Management, Ophthalmic

All 34
Devices cleared under the same product code (NFJ) and FDA review panel - the closest regulatory comparables to K132667.
Retina Workplace
K170638 · Carl Zeiss Meditec, AG · Jun 2017
Retina Workplace
K150467 · Carl Zeiss Meditec, AG · May 2015
FORUM GLAUCOMA WORKPLACE
K141297 · Carl Zeiss Meditec, AG · Oct 2014
FORUM GLAUCOMA WORKPLACE
K130648 · Carl Zeiss Meditec, AG · Jul 2013
CALLISTO EYE
K123464 · Carl Zeiss Meditec, AG · Mar 2013
FORUM FORUM ARCHIVE FORUM ARCHIVE & VIEWER FORUM ASSIST MATCH
K122938 · Carl Zeiss Meditec, AG · Nov 2012